Original Research

Accepted on 21 Nov 2024

Decoding the Prognostic Landscape of LUAD: The Interplay Between N6-methyladenosine Modification and Immune Microenvironment

in Cancer Immunity and Immunotherapy

Quan Chen
Weijun Wan
Qing Zhao
Juan Li
Yanli Xiong
Yuchuan Yuan
Lu Tang
Xiaofeng Wu
Wei Xing
Wei Guo

Frontiers in Immunology

doi 10.3389/fimmu.2024.1514497

Original Research

Accepted on 21 Nov 2024

Chemo-free Salvage Treatment Outperforms Traditional Chemotherapy in Advanced Lines of Relapsed/Refractory Subcutaneous Panniculitis-like T-cell Lymphoma

in Cancer Immunity and Immunotherapy

Chao Chen
Jingjing Yin
Wei Wang
Danqing Zhao
Chong Wei
Congwei Jia
Wei Zhang
Daobin Zhou
Yan Zhang

Frontiers in Immunology

doi 10.3389/fimmu.2024.1476875

Original Research

Published on 21 Nov 2024

Global trends and research hotspots in perioperative management of lung cancer: a bibliometric analysis from 2004 to 2024

in Cancer Immunity and Immunotherapy

Qinling Jiang
Zhuheng Wei
Pingping Liu
Zonghuai Li
Huiqin Jiang
Yilin Cao
Bo Zhang
Yuanyuan Yan
Yulong He

Frontiers in Immunology

doi 10.3389/fimmu.2024.1500686

306 views

Original Research

Published on 21 Nov 2024

The mechanism of PDE7B inhibiting the development of hepatocellular carcinoma through oxidative stress

in Cancer Immunity and Immunotherapy

Yunfeng Luo
Huaide Gao
Jianghua Zhao
Lin Chen
Jianguo Shao
Linling Ju

Frontiers in Immunology

doi 10.3389/fimmu.2024.1469740

153 views

Systematic Review

Accepted on 20 Nov 2024

Efficacy and safety of adding immune checkpoint inhibitors to standard therapy for recurrent or advanced cervical cancer: A meta-analysis of phase 3 clinical trials

in Cancer Immunity and Immunotherapy

Xinmiao Zhang
Jinhai Shen
Mengfan Huang
Rongxia Li

Frontiers in Immunology

doi 10.3389/fimmu.2024.1507977

102 views

Review

Accepted on 20 Nov 2024

Leveraging the Synergy Between Anti-Angiogenic Therapy and Immune Checkpoint Inhibitors to Treat Digestive System Cancers

in Cancer Immunity and Immunotherapy

Qinlan Xu
Dong Shao

Frontiers in Immunology

doi 10.3389/fimmu.2024.1487610

Original Research

Accepted on 20 Nov 2024

Immune-Related Diagnostic Markers for Benign Prostatic Hyperplasia and Their Potential as Drug Targets

in Cancer Immunity and Immunotherapy

YaXuan Wang
Jing Wang
Jibin Liu
Haixia Zhu

Frontiers in Immunology

doi 10.3389/fimmu.2024.1516362

Correction

Accepted on 20 Nov 2024

Case Report: Long Remission and Survival Following Immunotherapy in a Case of Pulmonary Pleomorphic Carcinoma

in Cancer Immunity and Immunotherapy

Muyang Chen
Tongshan Wang
Anpeng Wang
Hao Zhang

Frontiers in Immunology

doi 10.3389/fimmu.2024.1530843

Systematic Review

Accepted on 20 Nov 2024

Comparison of the Efficacy and Safety of Perioperative Immunochemotherapeutic Strategies for locally advanced esophageal cancer: a Systematic Review and Network Meta-analysis

in Cancer Immunity and Immunotherapy

Jiao Zhang
Peixi Zhao
Rui Xu
Le Han
Wenjuan Chen
Yili Zhang

Frontiers in Immunology

doi 10.3389/fimmu.2024.1478377

Case Report

Accepted on 20 Nov 2024

A novel third-generation anti-CD19/CD22 CAR T-cells combined with auto-HSCT for relapsed Burkitt lymphoma

in Cancer Immunity and Immunotherapy

XIAODAN LUO
Ao Chen
Le Qin
Robert Weinkove
Rong Zhao
Ting Ye
Sihui Chen
Jianli Tang
Jianbo Liu
Jiayu Huang

Frontiers in Immunology

doi 10.3389/fimmu.2024.1497736

Correction

Accepted on 20 Nov 2024

Corrigendum: Anti-cancer immune effect of human colorectal cancer neoantigen peptide based on MHC class I molecular affinity screening

in Cancer Immunity and Immunotherapy

Siyu Zhang
Changxin Huang
Yongqiang Li
Zhaoyang Li
Ying Zhu
Lili Yang
Haokun Hu
Quan Sun
Mengmeng Liu
Songqiang Cao

Frontiers in Immunology

doi 10.3389/fimmu.2024.1514836

Original Research

Published on 20 Nov 2024

Integrated single-cell and bulk RNA sequencing reveals immune-related SPP1+ macrophages as a potential strategy for predicting the prognosis and treatment of liver fibrosis and hepatocellular carcinoma

in Cancer Immunity and Immunotherapy

Bangjie Li
Jialiang Hu
Hanmei Xu

Frontiers in Immunology

doi 10.3389/fimmu.2024.1455383

319 views

Review

Published on 20 Nov 2024

The influence of immune checkpoint blockade on the outcomes of allogeneic hematopoietic stem cell transplantation

in Cancer Immunity and Immunotherapy

Yalei Hu
Yuxin Wang
Kaili Min
Huisheng Zhou
Xiaoning Gao

Frontiers in Immunology

doi 10.3389/fimmu.2024.1491330

245 views

Original Research

Published on 20 Nov 2024

Single-cell RNA sequencing reveals key molecular drivers and immune landscape in uveal melanoma: implications for targeted therapy and prognostic modeling

in Cancer Immunity and Immunotherapy

Zeyu Song
Wenwen Shao
Zhikai Xiahou
Yue Xu
Xiaofeng Zhang

Frontiers in Immunology

doi 10.3389/fimmu.2024.1493752

353 views

Original Research

Published on 20 Nov 2024

Discovery and preclinical evaluation of BPB-101: a novel triple functional bispecific antibody targeting GARP-TGF-β complex/SLC, free TGF-β and PD-L1

in Cancer Immunity and Immunotherapy

Wenxin Xu
Jieying Xu
Pingcui Li
Deyu Xu
Hongjie Cheng
Huan Zheng
Li Zhang
Mengmeng Liu
Siyuan Ye
Mengshi Jiang

Frontiers in Immunology

doi 10.3389/fimmu.2024.1479399

185 views

Original Research

Published on 20 Nov 2024

COVID-19 mitigates the response to TKIs in patients with CML via the inhibition of T-cell immunity

in Cancer Immunity and Immunotherapy

Na He
Guosheng Li
Jinting Liu
Wancheng Liu
Ruifeng Tian
Daoxin Ma

Frontiers in Immunology

doi 10.3389/fimmu.2024.1452035

319 views

Navigation group

Articles

Decoding the Prognostic Landscape of LUAD: The Interplay Between N6-methyladenosine Modification and Immune Microenvironment

Chemo-free Salvage Treatment Outperforms Traditional Chemotherapy in Advanced Lines of Relapsed/Refractory Subcutaneous Panniculitis-like T-cell Lymphoma

Global trends and research hotspots in perioperative management of lung cancer: a bibliometric analysis from 2004 to 2024

The mechanism of PDE7B inhibiting the development of hepatocellular carcinoma through oxidative stress

Efficacy and safety of adding immune checkpoint inhibitors to standard therapy for recurrent or advanced cervical cancer: A meta-analysis of phase 3 clinical trials

Leveraging the Synergy Between Anti-Angiogenic Therapy and Immune Checkpoint Inhibitors to Treat Digestive System Cancers

Immune-Related Diagnostic Markers for Benign Prostatic Hyperplasia and Their Potential as Drug Targets

Case Report: Long Remission and Survival Following Immunotherapy in a Case of Pulmonary Pleomorphic Carcinoma

Comparison of the Efficacy and Safety of Perioperative Immunochemotherapeutic Strategies for locally advanced esophageal cancer: a Systematic Review and Network Meta-analysis

A novel third-generation anti-CD19/CD22 CAR T-cells combined with auto-HSCT for relapsed Burkitt lymphoma

Corrigendum: Anti-cancer immune effect of human colorectal cancer neoantigen peptide based on MHC class I molecular affinity screening

Integrated single-cell and bulk RNA sequencing reveals immune-related SPP1+ macrophages as a potential strategy for predicting the prognosis and treatment of liver fibrosis and hepatocellular carcinoma

The influence of immune checkpoint blockade on the outcomes of allogeneic hematopoietic stem cell transplantation

Single-cell RNA sequencing reveals key molecular drivers and immune landscape in uveal melanoma: implications for targeted therapy and prognostic modeling

Discovery and preclinical evaluation of BPB-101: a novel triple functional bispecific antibody targeting GARP-TGF-β complex/SLC, free TGF-β and PD-L1

COVID-19 mitigates the response to TKIs in patients with CML via the inhibition of T-cell immunity